Immune Checkpoint Inhibitors and CVD Risk in Patients With Melanoma
Immune checkpoint inhibitor therapy may increase the risk of major atherosclerotic cardiovascular events in patients with high-risk or advanced melanoma.
Immune checkpoint inhibitor therapy may increase the risk of major atherosclerotic cardiovascular events in patients with high-risk or advanced melanoma.
At a median follow-up of 50.9 months, the median duration of response and median progression-free survival were not reached.
The American Gastroenterological Association outlined guiding principles to improve colorectal cancer screening nationwide, highlighting a need to eliminate financial barriers for patients.
A team of investigators conducted a systematic review and meta-analysis to provide to assess the risk for colorectal cancer in patients with inflammatory bowel disease.
A team of investigators performed a randomized controlled trial to compare outcomes following colon capsule endoscopy vs CT colonography for the detection of colorectal cancer.
The sensitivity of reflectance confocal microscopy is evaluated in the context of basal cell carcinoma diagnosis.